discontinuation risk ≥ 60%

Patients needing attention

Synthetic demo data

patients · discontinuation risk ≥ 60%

Create intervention

Most common reason

GI intolerance

Most effective previous action

GI-04

Nutritional protocol

Estimated addressable population

eligible for GI-04, confidence ≥ 70%

Predicted persistence gain

+17%

LLIFE OS insight · why this cohort goes where it goes

grounded · add an LLM key for prose

discontinuation risk ≥ 60%: 45 patients, mean day 136. 33% have deteriorating tolerance, 73% unstable GI, 100% carry ≥60% discontinuation risk; mean GI 63, adherence 57%. Dominant clusters: EC-03 53%, LT 47%.

Shared biology: Low microbial diversity 89%, Low butyrate capacity 78%, FUT2 non-secretor 67%, Baseline state S14 53%, Cluster EC-03 (high response / high intolerance) 53%, Adherence < 60% 53%, IL6 high-expression variant 47%. Dietary detractors: fat in 93%, lactose in 73%, histamine in 67%.

What worked: GI-04 improved 58% of 12; what did not: SC-12 improved only 56% of 9. By biology: GI-04 works best in Low butyrate capacity (67%) and worst in Baseline state S14 (44%); NP-02 works best in FUT2 non-secretor (60%) and worst in IL6 high-expression variant (50%).

No learned rules apply yet; run learning after the first campaign results.

Patient	Day	Baseline	GI	Tolerance	GI score	Discontinuation	Cluster
P-03067	150	S14	Unstable	Deteriorating	72	96%	EC-03
P-03078	139	S14	Unstable	Unstable	71	96%	EC-03
P-03177	140	S10	Unstable	Stable	81	96%	LT
P-03375	139	S14	Unstable	Deteriorating	71	96%	EC-03
P-03427	107	S14	Unstable	Favorable	68	96%	EC-03
P-03458	141	S14	Unstable	Stable	63	96%	EC-03
P-03486	93	S14	Unstable	Improving	78	96%	EC-03
P-03488	146	S14	Unstable	Improving	76	96%	EC-03
P-03345	140	S14	Unstable	Stable	69	95%	EC-03
P-03230	149	S09	Unstable	Improving	73	94%	EC-03
P-03058	140	S14	Unstable	Stable	67	93%	EC-03
P-03301	109	S12	Unstable	Favorable	70	91%	LT
P-03031	144	S14	Unstable	Improving	63	89%	EC-03
P-03459	145	S14	Improving	Improving	56	88%	EC-03
P-03034	138	S14	Unstable	Stable	78	85%	EC-03
P-03405	116	S14	Improving	Improving	58	84%	EC-03
P-03500	139	S14	Stable	Improving	52	81%	EC-03
P-03153	143	S08	Unstable	Deteriorating	67	80%	LT
P-03473	116	S01	Unstable	Deteriorating	61	79%	LT
P-03262	148	S14	Improving	Unstable	55	78%	EC-03
P-03419	146	S14	Improving	Favorable	50	78%	EC-03
P-03475	120	S14	Unstable	Deteriorating	68	78%	LT
P-03109	143	S03	Deteriorating	Deteriorating	58	76%	EC-03
P-03253	147	S15	Unstable	Stable	69	75%	LT
P-03361	150	S14	Unstable	Improving	63	75%	EC-03
P-03335	105	S12	Deteriorating	Deteriorating	49	73%	LT
P-03315	147	S06	Unstable	Improving	68	72%	LT
P-03133	148	S14	Unstable	Improving	60	71%	EC-03
P-03210	141	S14	Unstable	Unstable	61	71%	LT
P-03303	128	S16	Unstable	Stable	61	71%	LT
P-03273	119	S15	Unstable	Deteriorating	58	68%	LT
P-03041	143	S14	Improving	Deteriorating	51	67%	EC-03
P-03026	129	S02	Unstable	Deteriorating	65	66%	LT
P-03088	150	S14	Deteriorating	Favorable	48	65%	EC-03
P-03124	138	S14	Improving	Stable	49	64%	EC-03
P-03033	139	S12	Unstable	Improving	68	63%	LT
P-03105	138	S10	Unstable	Deteriorating	65	63%	LT
P-03218	138	S11	Unstable	Stable	72	62%	LT
P-03227	121	S05	Unstable	Deteriorating	62	62%	LT
P-03164	143	S12	Unstable	Stable	63	61%	LT
P-03008	147	S03	Unstable	Stable	64	60%	LT
P-03225	122	S10	Unstable	Deteriorating	59	60%	LT
P-03306	140	S14	Improving	Deteriorating	46	60%	EC-03
P-03367	146	S12	Unstable	Deteriorating	63	60%	LT
P-03370	149	S09	Deteriorating	Stable	55	60%	LT